ustransplant.org

Transplant Statistics: Annual Report : Reference Tables

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Table 13.6a
Immunosuppression Use for Induction, 1992 to 2001
Recipients with Heart-Lung Transplants

  Year of Transplant
1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
Transplants 48 60 71 69 39 61 47 51 48 27
Tx With Immunosuppression Info 46 58 68 69 35 58 45 50 47 25
No Induction Drugs Recorded 93.5% 87.9% 70.6% 50.7% 65.7% 70.7% 75.6% 66.0% 46.8% 24.0%
Drugs - - 0.0% 0.0% - - - - - -
ALG
ATG - - 22.1% 43.5% 22.9% 24.1% 15.6% 10.0% 27.7% 28.0%
NRATG/NRATS - - - - 5.7% 1.7% 4.4% 6.0% 2.1% -
OKT3 6.5% 12.1% 7.4% 7.2% 8.6% 6.9% 6.7% 10.0% 6.4% -
Thymoglobulin - - - - - - - 4.0% 4.3% 12.0%
Zenapax - - - - - - - 4.0% 12.8% 8.0%
Simulect 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 4.3% 32.0%

Source: OPTN/SRTR Data as of August 1, 2002.
(-) = Drug not used anytime during the year.
Induction drugs include any reported antilymphocyte antibodies and antibodies directed against lymphocyte
receptors.

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline

Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map

SRTR Site designed and maintained by Diamond Bullet Design & URREA.